Sorrento Therapeutics Inc (SRNE) stock has risen 76.99% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives SRNE stock a score of 84 out of a possible 100.
That rank is mainly influenced by a long-term technical score of 98. SRNE's rank also includes a fundamental score of 87. In addition to the average rating from Wall Street analysts, SRNE stock has a mean target price of 23. This means analysts expect the stock to rise 283.33% over the next 12 months. The short-term technical score for SRNE is 66.
What's Happening with SRNE Stock Today
Sorrento Therapeutics Inc (SRNE) stock has fallen -5.51% while the S&P 500 is lower by -1.92% as of 11:34 AM on Friday, Jun 26. SRNE is lower by -$0.35 from the previous closing price of $6.35 on volume of 16,340,045 shares. Over the past year the S&P 500 has gained 3.40% while SRNE has risen 76.99%. SRNE lost -$1.72 per share in the over the last 12 months.
Click Here to get the full Stock Score Report on Sorrento Therapeutics Inc (SRNE) Stock.
